Home  >  News
Eppen_PCR_Ape25
you can get e-magazine links on WhatsApp. Click here
News
  Basilea Pharmaceutica receives CHF 1.7 mn milestone payment from Asahi Kasei Pharma for strong sales of Cresemba in Japan,   April 26, 2025
  Daiichi Sankyo seeks Japanese approval for Enhertu to treat patients with HER2 positive metastatic solid tumours,   April 25, 2025
  Pharming receives positive recommendation from NICE for Joenja to treat APDS in adult and paediatric patients 12 years of age and older,   April 24, 2025
  Ascentage Pharma’s proprietary novel drugs, lisaftoclax & olverembatinib included in Chinese Society of Clinical Oncology 2025 Guidelines,   April 23, 2025
  Fujifilm Diosynth Biotechnologies& Regeneron ink a 10-year US manufacturing supply agreement valued at over $3 billion,   April 23, 2025
  China NMPA approves Rona Therapeutics’ IND application for RN1871, a novel AGT-targeting siRNA drug for hypertension,   April 22, 2025
  Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the US over the next five years,   April 22, 2025
  Zimmer Biomet completes acquisition of medical device company, Paragon 28,   April 22, 2025
  Alumis and Acelyrin announce amended merger agreement,   April 22, 2025
  Viatris seeks Japan’s MHLW approval for Effexor SR capsules to treat generalized anxiety disorder,   April 22, 2025
  Amneal Pharma recalls ropivacaine hydrochloride injection, USP 500mg/100mL, due to the potential presence of particulate matter,   April 21, 2025
  FesariusTherapeutics inks manufacturing & supply agreement with Regenity Biosciences for DermiSphere hDRT, the first hydrogel dermal regeneration template,   April 19, 2025
  Meribel Pharma Solutions launches network across Europe to elevate pharma services to new heights,   April 17, 2025
  Scipher Medicine inks partnership with Kythera Labs to unlock new insights into autoimmune disease-specific treatment,   April 17, 2025
  ImmunityBio announces US FDA submissions of sBLA for NMIBC papillary disease and EAP for Anktiva to treat lymphopenia,   April 17, 2025
  Atsena Therapeutics receives US FDA’s RMAT designation for ATSN-201 gene therapy to treat X-linked Retinoschisis,   April 17, 2025
  Roche’s bispecific antibody, Columvi receives European approval for diffuse large B-cell lymphoma after initial therapy,   April 15, 2025
  Adaptin Bio completes alternative public offering and closes $7.7 million private placement,   April 12, 2025
  Bausch Health, Canada & pCPA sign LoI for public drug plan coverage of PrCABTREO for treatment of acne vulgaris,   April 12, 2025
  Bayer seeks EMA approval for aflibercept 8 mg for treatment of retinal vein occlusion,   April 10, 2025

 Back
 
Avians_2025
CPhI_Japan2025
API_China_2025
chemexpoindia
ana-Lab-India_25
ProPak_Asia_2025
Oligonucleotides_Workshop25
CPHI_PMEC_China_2025
Pharmatech_Lab_Expo2025
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram